317 related articles for article (PubMed ID: 16798883)
1. B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival.
Krambeck AE; Thompson RH; Dong H; Lohse CM; Park ES; Kuntz SM; Leibovich BC; Blute ML; Cheville JC; Kwon ED
Proc Natl Acad Sci U S A; 2006 Jul; 103(27):10391-10396. PubMed ID: 16798883
[TBL] [Abstract][Full Text] [Related]
2. Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy.
Thompson RH; Dong H; Kwon ED
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):709s-715s. PubMed ID: 17255298
[TBL] [Abstract][Full Text] [Related]
3. Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target.
Thompson RH; Gillett MD; Cheville JC; Lohse CM; Dong H; Webster WS; Krejci KG; Lobo JR; Sengupta S; Chen L; Zincke H; Blute ML; Strome SE; Leibovich BC; Kwon ED
Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17174-9. PubMed ID: 15569934
[TBL] [Abstract][Full Text] [Related]
4. Higher preoperative serum levels of PD-L1 and B7-H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF-targeted therapy and unfavorable prognosis of renal cell carcinoma.
Fukuda T; Kamai T; Masuda A; Nukui A; Abe H; Arai K; Yoshida K
Cancer Med; 2016 Aug; 5(8):1810-20. PubMed ID: 27292320
[TBL] [Abstract][Full Text] [Related]
5. Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma.
Crispen PL; Sheinin Y; Roth TJ; Lohse CM; Kuntz SM; Frigola X; Thompson RH; Boorjian SA; Dong H; Leibovich BC; Blute ML; Kwon ED
Clin Cancer Res; 2008 Aug; 14(16):5150-7. PubMed ID: 18694993
[TBL] [Abstract][Full Text] [Related]
6. Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.
Thompson RH; Kuntz SM; Leibovich BC; Dong H; Lohse CM; Webster WS; Sengupta S; Frank I; Parker AS; Zincke H; Blute ML; Sebo TJ; Cheville JC; Kwon ED
Cancer Res; 2006 Apr; 66(7):3381-5. PubMed ID: 16585157
[TBL] [Abstract][Full Text] [Related]
7. B7-H1 glycoprotein blockade: a novel strategy to enhance immunotherapy in patients with renal cell carcinoma.
Thompson RH; Webster WS; Cheville JC; Lohse CM; Dong H; Leibovich BC; Kuntz SM; Sengupta S; Kwon ED; Blute ML
Urology; 2005 Nov; 66(5 Suppl):10-4. PubMed ID: 16194701
[TBL] [Abstract][Full Text] [Related]
8. Significance of B7-H1 overexpression in kidney cancer.
Thompson RH; Kwon ED
Clin Genitourin Cancer; 2006 Dec; 5(3):206-11. PubMed ID: 17239274
[TBL] [Abstract][Full Text] [Related]
9. Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma.
Thompson RH; Gillett MD; Cheville JC; Lohse CM; Dong H; Webster WS; Chen L; Zincke H; Blute ML; Leibovich BC; Kwon ED
Cancer; 2005 Nov; 104(10):2084-91. PubMed ID: 16208700
[TBL] [Abstract][Full Text] [Related]
10. The costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translocating into nucleus.
Zhang L; Wu H; Lu D; Li G; Sun C; Song H; Li J; Zhai T; Huang L; Hou C; Wang W; Zhou B; Chen S; Lu B; Zhang X
Oncogene; 2013 Nov; 32(46):5347-58. PubMed ID: 23318460
[TBL] [Abstract][Full Text] [Related]
11. B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma.
Chen LJ; Sun J; Wu HY; Zhou SM; Tan Y; Tan M; Shan BE; Lu BF; Zhang XG
Cancer Immunol Immunother; 2011 Jul; 60(7):1047-55. PubMed ID: 21519829
[TBL] [Abstract][Full Text] [Related]
12. PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma.
Thompson RH; Dong H; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Kwon ED
Clin Cancer Res; 2007 Mar; 13(6):1757-61. PubMed ID: 17363529
[TBL] [Abstract][Full Text] [Related]
13. B7-H1 and B7-H4 expression in colorectal carcinoma: correlation with tumor FOXP3(+) regulatory T-cell infiltration.
Zhao LW; Li C; Zhang RL; Xue HG; Zhang FX; Zhang F; Gai XD
Acta Histochem; 2014 Sep; 116(7):1163-8. PubMed ID: 25053455
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of IL-4 and TNFα on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation.
Quandt D; Jasinski-Bergner S; Müller U; Schulze B; Seliger B
J Transl Med; 2014 May; 12():151. PubMed ID: 24885059
[TBL] [Abstract][Full Text] [Related]
15. B7-H4 is preferentially expressed in non-dividing brain tumor cells and in a subset of brain tumor stem-like cells.
Yao Y; Wang X; Jin K; Zhu J; Wang Y; Xiong S; Mao Y; Zhou L
J Neurooncol; 2008 Sep; 89(2):121-9. PubMed ID: 18478183
[TBL] [Abstract][Full Text] [Related]
16. Prognostic investigations of B7-H1 and B7-H4 expression levels as independent predictor markers of renal cell carcinoma.
Safaei HR; Rostamzadeh A; Rahmani O; Mohammadi M; Ghaderi O; Yahaghi H; Ahmadi K
Tumour Biol; 2016 Jun; 37(6):7583-7. PubMed ID: 26687644
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer.
Arigami T; Uenosono Y; Ishigami S; Hagihara T; Haraguchi N; Natsugoe S
World J Surg; 2011 Sep; 35(9):2051-7. PubMed ID: 21748517
[TBL] [Abstract][Full Text] [Related]
18. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma.
Kryczek I; Zou L; Rodriguez P; Zhu G; Wei S; Mottram P; Brumlik M; Cheng P; Curiel T; Myers L; Lackner A; Alvarez X; Ochoa A; Chen L; Zou W
J Exp Med; 2006 Apr; 203(4):871-81. PubMed ID: 16606666
[TBL] [Abstract][Full Text] [Related]
19. Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer.
Jiang J; Zhu Y; Wu C; Shen Y; Wei W; Chen L; Zheng X; Sun J; Lu B; Zhang X
Cancer Immunol Immunother; 2010 Nov; 59(11):1707-14. PubMed ID: 20725832
[TBL] [Abstract][Full Text] [Related]
20. Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma.
Krambeck AE; Dong H; Thompson RH; Kuntz SM; Lohse CM; Leibovich BC; Blute ML; Sebo TJ; Cheville JC; Parker AS; Kwon ED
Clin Cancer Res; 2007 Mar; 13(6):1749-56. PubMed ID: 17363528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
